Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gefen Aldouby-Bier"'
Autor:
Amichai Perlman, Ehud Horwitz, Bruria Hirsh-Raccah, Gefen Aldouby-Bier, Tamar Fisher Negev, Sarit Hochberg-Klein, Yosef Kalish, Mordechai Muszkat
Publikováno v:
Israel Journal of Health Policy Research, Vol 8, Iss 1, Pp 1-9 (2019)
Abstract Introduction In the past decade, direct-acting oral anticoagulants (DOAC) have been introduced to medical practice for several indications, with a wide range of dosing regimens. As both over- and under-dosing might lead to life-threatening e
Externí odkaz:
https://doaj.org/article/0ccf37aade114284b9ab8328a92b297b
Autor:
Yosef Kalish, Tamar Fisher Negev, Bruria Hirsh-Raccah, Amichai Perlman, Ilan Matok, Gil Dagan, Sarit Hochberg-Klein, Lotan Choshen Cohen, Laurent Azoulay, Ehud Horwitz, Mordechai Muszkat, Gefen Aldouby-Bier
Publikováno v:
Journal of Thrombosis and Thrombolysis. 47:590-595
Little is known regarding the management of direct oral anticoagulants (DOACs) in patients with enzyme-inducing drugs (EID). The use of EID may lead to sub-therapeutic concentrations of DOACs and to treatment failure. Thus, many patients on EIDs cann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef4482210a456a70abff2b9669d9d004
https://doi.org/10.1007/s11239-018-01804-7
https://doi.org/10.1007/s11239-018-01804-7
Autor:
Yosef Kalish, Bruria Hirsh-Raccah, Gefen Aldouby-Bier, Tamar Fisher Negev, Mordechai Muszkat, Ehud Horwitz, Amichai Perlman, Sarit Hochberg-Klein
Publikováno v:
Israel Journal of Health Policy Research
Israel Journal of Health Policy Research, Vol 8, Iss 1, Pp 1-9 (2019)
Israel Journal of Health Policy Research, Vol 8, Iss 1, Pp 1-9 (2019)
Introduction In the past decade, direct-acting oral anticoagulants (DOAC) have been introduced to medical practice for several indications, with a wide range of dosing regimens. As both over- and under-dosing might lead to life-threatening events, de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a826fcb00331ff99b53419cab74dda73
https://doi.org/10.1186/s13584-019-0285-9
https://doi.org/10.1186/s13584-019-0285-9
Publikováno v:
Molecular pharmaceutics. 15(4)
Phase II biotransformation reactions have been gaining more attention due to their acknowledged significance in drug bioavailability, drug development, and drug-drug interactions. However, the predominant role of phase I metabolism has always oversha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f31d74b85631cb83cd6c8ae4d739ed5
https://pubmed.ncbi.nlm.nih.gov/29537855
https://pubmed.ncbi.nlm.nih.gov/29537855